Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Uhde, a major chemical technology solution provider, in partnership with Novonesis, a pioneer in enzymatic technology, have launched their joint offering: uhde® enzymatic esterification.
Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here.
DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...